Trial
NCT03865407
Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Virginia Commonwealth University
Collaborators
—
Condition
Hyperuricemia
Intervention
Allopurinol
Why stopped
inability to achieve recruitment goals at a single center and given the current pandemic conditions
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-27